PMC:7376974 / 87682-88470
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T421 | 222-225 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T422 | 238-241 | Body_part | denotes | DNA | http://purl.org/sig/ont/fma/fma74412 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1584 | 226-229 | Gene | denotes | Env | Gene:30816 |
| 1585 | 312-315 | Gene | denotes | Env | Gene:30816 |
| 1586 | 387-392 | Gene | denotes | IFN-γ | Gene:15978 |
| 1587 | 363-366 | Gene | denotes | Env | Gene:17276 |
| 1588 | 449-453 | Species | denotes | mice | Tax:10090 |
| 1589 | 18-28 | Chemical | denotes | fullerenol | MESH:C108127 |
| 1590 | 82-92 | Chemical | denotes | fullerenol | MESH:C108127 |
| 1591 | 139-148 | Chemical | denotes | fullerene | MESH:D037741 |
| 1592 | 184-185 | Chemical | denotes | C | MESH:D002244 |
| 1593 | 283-293 | Chemical | denotes | fullerenol | MESH:C108127 |
| 1594 | 329-339 | Chemical | denotes | fullerenol | MESH:C108127 |
| 1595 | 630-640 | Chemical | denotes | Fullerenol | MESH:C108127 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T810 | 62-63 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T811 | 194-195 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T48471 | 35-43 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
| T3391 | 139-148 | Chemical | denotes | fullerene | http://purl.obolibrary.org/obo/CHEBI_33416 |
| T16718 | 186-191 | Chemical | denotes | atoms | http://purl.obolibrary.org/obo/CHEBI_33250 |
| T80645 | 238-241 | Chemical | denotes | DNA | http://purl.obolibrary.org/obo/CHEBI_16991 |
| T93663 | 299-302 | Chemical | denotes | TEM | http://purl.obolibrary.org/obo/CHEBI_27919 |
| T94403 | 380-385 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T39840 | 387-390 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T15260 | 660-667 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T533 | 0-629 | Sentence | denotes | Figure 17 Use of fullerenol as co-adjuvant for vaccination. (a) The structure of fullerenol, red balls represent O and white for H on the fullerene surface, and green balls represent C atoms. (b) The schematic diagram of HIV Env plasmid DNA encapsulated during the self-assembly of fullerenol. (c) TEM image of Env entrapped by fullerenol. (d) Compared to naked Env immunization group, IFN-γ production (immunospot) was significantly enhanced when mice were immunized with the formulation via various immunization routes, including intradermal (i.d.), intramuscular (i.m.), subcutaneous (s.c.), and intranasal (i.n.) injections. |
| T534 | 630-706 | Sentence | denotes | Fullerenol could decrease the antigen dosage (e) and immunization times (f). |
| T535 | 707-749 | Sentence | denotes | Reproduced with permission from ref (141). |
| T536 | 750-788 | Sentence | denotes | Copyright 2013 John Wiley & Sons, Inc. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32667191-23963730-153401 | 744-747 | 23963730 | denotes | 141 |